Optimizing the role of FDG PET–CT for potentially operable metastatic colorectal cancer

被引：0
|
作者：
A. D. Culverwell
F. U. Chowdhury
A. F. Scarsbrook
机构：
[1] Leeds Teaching Hospitals NHS Trust,Departments of Clinical Radiology and Nuclear Medicine
[2] St James’s University Hospital,Department of Nuclear Medicine
来源：
Abdominal Imaging | 2012年 / 37卷
关键词：
Colonic carcinoma; Rectal carcinoma; Fluorine fluorodeoxyglucose; Positron emission tomography–computed tomography; Metastatic disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Recent treatment advances now allow a realistic chance of cure in selected patients with metastatic colorectal carcinoma (CRC). Accurate pre-treatment staging is crucial to ensure appropriate management by identification of patients with more advanced disease who will not benefit from surgery. 18Fluorine 2-fluoro-2-deoxy-d-glucose positron emission tomography–computed tomography (PET–CT) has a firmly established role in staging, restaging, and recurrence detection of a range of tumors. This article will review the role of PET–CT in patients with CRC with a particular emphasis on optimizing the technique in patients with potentially operable metastatic disease.
引用
收藏
页码：1021 / 1031
页数：10
相关论文
共 50 条
  • [31] Role of FDG-PET/CT in Metastatic Staging of Newly Diagnosed Primary Breast Cancer
    Niikura, N.
    Costelloe, C.
    Madewell, J. E.
    Hayashi, N.
    Yu, T-K
    Liu, J.
    Palla, S. L.
    Tokuda, Y.
    Theriault, R. L.
    Hortobagyi, G. N.
    Ueno, N. T.
    CANCER RESEARCH, 2010, 70
  • [32] Dual-phase FDG PET/CT for predicting prognosis in operable breast cancer
    Ikejiri, Haruka
    Sasada, Shinsuke
    Emi, Akiko
    Masumoto, Norio
    Kadoya, Takayuki
    Okada, Morihito
    BREAST, 2022, 65 : 98 - 103
  • [33] The role of FDG PET-CT in the evaluation of patients with colorectal cancer. Interobserver study
    Tuncel, M.
    Vargol, S. E.
    Bariskanat, N.
    Topbas, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S581 - S581
  • [34] The Role of FDG PET/CT for the Diagnosis of Urothelial Cancer
    Nishiyama, T.
    Ashikari, A.
    Namitome, R.
    Yagi, Y.
    Kono, Y.
    Toya, K.
    Yorozu, A.
    Saito, S.
    UROLOGY, 2012, 80 (03) : S202 - S202
  • [35] Monitoring liver resection for metastatic colorectal cancer with FDG-PET.
    Oyen, WJ
    Langenhoff, BS
    Ruers, TJ
    Jager, GJ
    Corstens, FH
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 308P - 308P
  • [36] Prognostic parameters in recurrent colorectal cancer: A role of control or restaging by FDG-PET/CT
    Hancerliogullari, Oguz
    Okuyucu, Kursat
    Ince, Semra
    Peker, Subutay
    Arslan, Nuri
    VOJNOSANITETSKI PREGLED, 2020, 77 (02) : 201 - 208
  • [37] Prediction of therapy outcome with FDG PET in metastatic colorectal cancer.
    Dimitrakopoulou-Strauss, A
    Strauss, LG
    Rudi, J
    Burger, C
    Haberkorn, U
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 25P - 25P
  • [38] The role of PET/CT in restaging of colorectal cancer
    Valotassiou, V.
    Malamitsi, J.
    Efthimiadou, R.
    Pagou, M.
    Rousakis, A.
    Andreou, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S121 - S121
  • [39] Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma:: A prospective study compared with conventional imaging
    Kim, Ji Y.
    Kim, Myung-Hwan
    Lee, Tae Y.
    Hwang, Chang Y.
    Kim, Jae S.
    Yun, Sung-Cheol
    Lee, Sang S.
    Seo, Dong W.
    Lee, Sung K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (05): : 1145 - 1151
  • [40] The Role of F-18-FDG PET/CT in Colorectal Neoplasm
    Kim, Kyung-Jo
    INTESTINAL RESEARCH, 2010, 8 (01) : 84 - 86
12345